SCHEMBL20022402

SCHEMBL20022402

Cc1oc(-c2cccnc2)nc1C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 1/20 0.58
TARBP2 Q15633 2/20 0.49
F2 P00734 1/20 0.49
ELANE P08246 1/20 0.48
KDM4E B2RXH2 5/20 0.48
RAB9A P51151 3/20 0.48
ALDH1A1 P00352 3/20 0.48
NPC1 O15118 2/20 0.48
HSD17B10 Q99714 2/20 0.48
TP53 P04637 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
HPGD P15428 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
LMNA P02545 1/20 0.47
HTT P42858 1/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179708 0.84 TARBP2 (0.64) IKBKBTARBP2KDM4ERAB9AALDH1A1
Hydrochloric Acid SCHEMBL11622676 0.83 TARBP2 (0.62) IKBKBTARBP2KDM4ERAB9AALDH1A1
SCHEMBL20022403 0.82 TARBP2 (0.70) IKBKBTARBP2KDM4ERAB9AALDH1A1
SCHEMBL2112745 0.81 IKBKB (0.56) IKBKBF2ELANEKDM4ERAB9A
SCHEMBL29408277 0.80 TARBP2 (0.43) IKBKBTARBP2KDM4ERAB9AALDH1A1
SCHEMBL28698193 0.80 TARBP2 (0.43) IKBKBTARBP2KDM4ERAB9AALDH1A1
SCHEMBL4030129 0.79 KDM4E (0.74) IKBKBF2ELANEKDM4ERAB9A
SCHEMBL20026597 0.79 IKBKB (0.51) IKBKBTARBP2F2KDM4ERAB9A
SCHEMBL4024618 0.78 AKR1C3 (0.47) IKBKBF2ELANEKDM4ERAB9A
SCHEMBL1803772 0.78 ALDH1A1 (0.55) IKBKBF2ELANEKDM4ERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180093968-A1 QUINOLINE DERIVATIVES AS TAM RTK INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2018-04-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180093968-A1 QUINOLINE DERIVATIVES AS TAM RTK INHIBITORS TYRO3, MERTK, AXL IKBKB 628/4885TARBP2 3739/4885F2 4852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.